Business US generic business growth robust in June quarter Last updated: September 16, 2024 12:35 pm Sangeetha G 0 Min Read SHARE Chennai: Indian pharma companies in the US generic business reported robust growth in the first quarter of FY25. The growth has been strong in the past few quarters. In 1QFY25, the US generic … This post was originally published on this site Previous Article The environment was meant to be ‘back on the priority list’ under Labor. Instead, we’ve seen a familiar story Next Article Scientists show how pregnancy changes the brain in innumerable ways